Shareablee Inc
Total Consideration
$31.4M
COMSCORE, INC. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Cash-Flow Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$-2
Book Value Per Share
$21
Free Cash Flow Per Share
$4
Cash Per Share
$4
Revenue Per Share
$67
OCF Per Share
$4
Return on Equity
-19.4%
Return on Assets
-2.4%
Return on Invested Capital
3.8%
Debt to Equity
0.37
Current Ratio
0.78
Quick Ratio
0.78
Asset Turnover
0.85
Days Sales Outstanding
58.47
Days Payables Outstanding
29.09
R&D / Revenue
8.4%
SBC / Revenue
0.7%
Capex / Revenue
0.3%
Working Capital
$-27M
Net Current Asset Value
$-110M
Invested Capital
$153M
OCF / Net Income
-2.27
FCF / Net Income
-2.18
Accruals Ratio (Sloan)
-8.0%
Net Debt
$18M
Net Debt / EBITDA
0.63
Interest Coverage
-0.67
Cash Coverage
-3.40
Dividend Coverage
—
Capex Coverage
23.78
Tangible Common Equity
$-140M
TCE / Total Assets
-34.3%
Goodwill / Total Assets
61.0%
NOPAT
$4M
Cash ROIC
23.4%
WC / Revenue
-7.4%
Capex / D&A
0.04
Reinvestment Rate
-505.4%
Total Payout Ratio
—
Asset Growth vs Revenue Growth
-5.6%
Revenue 5Y CAGR
0.1%
FCF 5Y CAGR
146.4%
EBITDA 5Y CAGR
—
Book Value 5Y CAGR
-13.4%
Stock Price (FY-end)
$7
Market Cap
$34M
P/S Ratio
0.10
P/B Ratio
0.31
P/TB Ratio
—
P/OCF Ratio
1.52
P/FCF Ratio
1.58
Enterprise Value
$52M
EV / EBITDA
1.86
EV / Sales
0.15
EV / FCF
2.41
FCF Yield
63.1%
Dividend Yield
—
Shareholder Yield
-7.7%
Buyback Yield
—
R&D Yield
87.5%
Capex Yield
2.8%
Dividend Per Share
—
Operating Leverage
1.86
Graham Number
—
Shares Variation (YoY)
5.9%
Beta (5Y)
1.10
Cost of Equity
10.0%
Cost of Debt (after tax)
-12.7%
WACC
-2.4%
ROIC - WACC Spread
6.3%
52W High
$9
52W Low
$5
Trailing Return 1Y
12.7%
Trailing Return 5Y
-85.3%
F-Score (Piotroski)
4.00
Z-Score (Altman)
-3.98
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.
EPS — Consensus vs Actual
Revenue — Consensus vs Actual
Stock Price on Earnings Dates
COMSCORE, INC. — Effective Tax Rate ReconciliationNEW
Bridges from the federal statutory rate (21% post-TCJA) to the effective tax rate via the issuer's tax-note reconciliation lines. Sourced from EffectiveIncomeTaxRateReconciliation* flat CompanyFacts concepts. Conditional lines (R&D credits, FDII, SBC, valuation allowance, etc.) only render when the issuer discloses them. Persistent divergence between accrual tax expense and cash taxes paid is a leading signal for deferred-tax buildup.
Effective Rate Trend
| Reconciliation Line | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Federal Statutory Rate | 21.00% | 21.00% | 21.00% | 21.00% | 21.00% | 21.00% |
| State & Local Income Taxes | -0.50% | -1.50% | -0.30% | 0.40% | 0.50% | -11.20% |
| Foreign Rate Differential | -1.80% | -1.20% | -0.40% | -0.30% | -0.40% | — |
| Other Adjustments | 1.10% | -0.20% | -1.70% | -1.00% | 0.00% | — |
| Nondeductible Expenses | 0.00% | -3.60% | 3.70% | -0.50% | -0.80% | -1.60% |
| Valuation Allowance Change | 5.90% | -16.10% | -10.70% | -4.90% | -3.90% | — |
| Tax Law Change | — | — | — | — | — | — |
| Effective Tax Rate | -1.90% | -1.70% | -2.70% | -2.00% | -1.60% | -23.90% |
Cash vs Accrual
| Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Income Tax Expense (Accrual) | $902.0K | $859.0K | $1.7M | $1.5M | $924.0K | $1.9M |
| Income Taxes Paid (Cash) | $1.2M | $1.8M | $1.8M | $2.1M | $1.3M | $768.0K |
COMSCORE, INC. — M&A AcquisitionsNEW
Per-deal acquisition disclosures sourced from us-gaap:BusinessAcquisitionAxis dimensional XBRL. Each card surfaces the deal's purchase-price allocation (goodwill vs intangibles vs liabilities), contingent consideration (unpaid earn-outs), and pro-forma combined-entity numbers. Probability-of-Success (PoS) factor on biotech targets is the ASC 805 contingent-consideration valuation — higher = closer to commercialization, higher implied target value.
COMSCORE, INC. — RestructuringNEW
Per-category restructuring disclosures sourced from us-gaap:RestructuringCostAndReserveAxis dimensional XBRL. Negative charges indicate reversals of prior accruals (a sign the original estimate was too aggressive — flattering current-period earnings).
As of 2025-12-31
| Category | Class | P&L Charge | Cash Paid | Reserve Balance |
|---|---|---|---|---|
| Employee Severance | Employee Severance | +$788.0K | $321.0K | — |
| Other Restructuring | Other | +$239.0K | $23.0K | — |